1. Home
  2. UMH vs OGN Comparison

UMH vs OGN Comparison

Compare UMH & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UMH Properties Inc.

UMH

UMH Properties Inc.

HOLD

Current Price

$15.40

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.74

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
OGN
Founded
1968
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
UMH
OGN
Price
$15.40
$13.74
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
★ $17.75
$11.40
AVG Volume (30 Days)
624.3K
★ 2.5M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
★ 5.84%
0.60%
EPS Growth
★ 133.33
N/A
EPS
0.08
★ 0.95
Revenue
$261,754,000.00
★ $6,216,000,000.00
Revenue This Year
$5.51
$0.45
Revenue Next Year
$2.51
$1.67
P/E Ratio
$191.63
★ $14.44
Revenue Growth
★ 8.81
N/A
52 Week Low
$13.93
$5.69
52 Week High
$16.77
$13.79

Technical Indicators

Market Signals
Indicator
UMH
OGN
Relative Strength Index (RSI) 39.23 59.92
Support Level $15.13 $13.46
Resistance Level $15.75 $13.79
Average True Range (ATR) 0.24 0.04
MACD -0.05 -0.00
Stochastic Oscillator 28.40 70.00

Price Performance

Historical Comparison
UMH
OGN

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: